CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 180 enrolled
Drug / intervention
Dexamethasone +2 moredrug
Likely dose
Dexamethasone 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00825071
NCT00825071Phase 4Completed
CompareCT.gov

Optimizing Anesthesia Antiemetic Measures Versus Combination With Dexamethasone or Ondansetron in the Prevention of Postoperative Nausea and Vomiting.

University of Jordan·interventional·Posted Jan 19, 2009·Updated May 13, 2016

In Brief

A Phase 4 clinical trial evaluating Dexamethasone, Ondansetron, and 1 other intervention for Postoperative Nausea and Vomiting. Completed, enrolled 180 participants across 1 site.

Detailed Summary

The investigators want to test the efficacy of these anesthetic antiemetic measures collectively with or without ondansetron or dexamethasone, in the prevention of postoperative nausea and vomiting (PONV) in patients undergoing laparoscopic cholecystectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Nausea and Vomiting
CountriesJordan
Collaborators--

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 19, 2009
Enrollment StartNov 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.5 years ago

Interventions

Dexamethasonedrug

8 mg, Intravenous

Ondansetrondrug

4 mg, intravenously

normal salinedrug

2 ml, intravenously